Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849(CV9202), combined with local radiation treatment in patients with stage IVnon-small cell lung cancer
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
08 February 2019
|
| In: |
Journal for ImmunoTherapy of Cancer
Year: 2019, Volume: 7, Issue: 1 |
| ISSN: | 2051-1426 |
| DOI: | 10.1186/s40425-019-0520-5 |
| Online Access: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s40425-019-0520-5 |
| Author Notes: | Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt & Alfred Zippelius |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 2051-1426 |
| DOI: | 10.1186/s40425-019-0520-5 |